International Journal of Clinical Pharmacy

, Volume 36, Issue 4, pp 800–806 | Cite as

Effectiveness of a community pharmacy weight management programme

Research Article


Background Obesity is a growing problem in England with one quarter of the adult population being obese and around 60 % being overweight or obese. Given the high costs of treating obesity-related conditions such as coronary heart disease and type-2 diabetes the UK Government aims to reduce obesity through public health services including those provided by community pharmacists. Objective To evaluate the effectiveness of a community pharmacy weight management clinic in assisting obese patients to reduce their weight. Setting Community pharmacies across four Primary Care Trusts in England. Methods Retrospective analysis of data collected by pharmacies providing weight management programmes. The service involved measurement with provision of advice and support. Data analysis consisted of frequency counts, percentages and means with standard deviations (SD) for demographic and biometric variables. Paired t tests were used to compare weight, waist circumference and blood pressure at 3 and 6 months. Main outcome measure Weight change at 3 months. Results 281 patients attended the programme across four Primary Care Trusts. Three-quarters were female, mean age 52.8 years (SD ± 14.4) and mean baseline weight 96.3 kg (SD ± 15.7). At 3 months patients had lost weight (mean change = −3.07 kg) and waist circumference (mean change = −3.87 cm), but there was no difference in blood pressure. After 6 months weight and waist circumference were further reduced from baseline (mean change = −4.59 kg, −4.79 cm respectively) and there was a reduction in blood pressure (mean change systolic = −9.5 mmHg; diastolic = −4.7 mmHg). Conclusion The study has demonstrated that reductions in weight and waist circumference can be achieved in patients who participate in a community pharmacy weight management programme.


Community pharmacy England Obesity Overweight Weight management 



Alliance Healthcare provided the service documentation, information about the service and the data for analysis to the authors, but had no influence on the study.


This study was funded by Alliance Healthcare.

Conflicts of interest

The authors declare that they have no conflicts of interest.


  1. 1.
    The NHS Information Centre. Lifestyles statistics: statistics on obesity, physical activity and diet: England, 2012. Published 23 February 2013, cited 7 June 2013.
  2. 2.
    Haslam D, James W. Obesity. Lancet. 2005;366:1197–209.PubMedCrossRefGoogle Scholar
  3. 3.
    Wolf H, Tuomilehto J, Kuulasmaa K, Domarkiene S, Cepaitis Z, Molarius A, et al. Blood pressure levels in the 41 populations of the WHO MONICA Project. J Hum Hypertens. 1997;11:733–42.PubMedCrossRefGoogle Scholar
  4. 4.
    Cassano P, Segal M, Vokonas P, Weiss S. Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study. Ann Epidemiol. 1990;1:33–48.PubMedCrossRefGoogle Scholar
  5. 5.
    Stevens J, Couper D, Pankow J, Folsom AR, Duncan BB, Nieto FJ, et al. Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obesity. 2001;9:696–705.CrossRefGoogle Scholar
  6. 6.
    Kopelman P. Health risks associated with overweight and obesity. Obes Rev. 2007;8(Suppl 1):13–7.PubMedCrossRefGoogle Scholar
  7. 7.
    National Institute for Health and Care Excellence. CG43 Obesity: quick reference guide 2 for the NHS. Published 29 January 2010, cited 7 June 2013.
  8. 8.
    Lang A. Froelicher ES: Management of overweight and obesity in adults: behavioral intervention for long-term weight loss and maintenance. Eur J Cardiovasc Nurs. 2006;5:102–14.PubMedCrossRefGoogle Scholar
  9. 9.
    Department of Health. Healthy lives, healthy people: our strategy for public health in England. Published 30 November 2010, cited 7 June 2013.
  10. 10.
    Hardcastle S, Taylor A, Bailey M, Castle R. A randomised controlled trial on the effectiveness of a primary health care based counselling intervention on physical activity, diet and CHD risk factors. Patient Educ Couns. 2008;70:31–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Counterweight Project Team. Evaluation of the counterweight programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract. 2008;58:548–54.PubMedCentralCrossRefGoogle Scholar
  12. 12.
    Bush J, Langley CA, Patel A, Harvey JE. Evaluation of the Heart of Birmingham teaching Primary Care Trust (HoBtPCT) my choice weight management programme. Published December 2011, cited 7 June 2013.
  13. 13.
    Morrison D, McLoone P, Broshnahan N, McCombie L, Smith A, Gordon J. A community pharmacy weight management programme: an evaluation of effectiveness. BMC Public Health. 2013;13:282.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Blackburn G. Effect of degree of weight loss on health benefits. Obes Res. 1995;3(Suppl 2):211s–6s.PubMedCrossRefGoogle Scholar
  15. 15.
    Jolly K, Lewis A, Beach J, Denley J, Adab P, Deeks JJ, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten up randomised controlled trial. BMJ. 2011;343:d6500.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Counterweight Project Team. The implementation of the Counterweight Programme in Scotland, UK. Fam Pract. 2012;29:139–44.CrossRefGoogle Scholar
  17. 17.
    Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878–84.PubMedCrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  1. 1.School of PharmacyUniversity of NottinghamNottinghamUK
  2. 2.School of Community Health SciencesUniversity of NottinghamNottinghamUK

Personalised recommendations